Usual daily food intake after chemotherapy
The proportion of patients reporting maintenance of usual daily food intake during the overall period after cisplatin administration was similar in both treatment groups: 69.7% (95% CI, 58.6 to 78.9) in the DEX1 group vs. 72.4% (95% CI, 61.4 to 81.2) in the DEX4 group (Proportion of patients reporting usual daily food intake in acute, delayed, and overall phases. Error bars represent 95% confidence interval. NEPA, fixed combination of netupitant and palonosetron; DEX1, dexamethasone day 1; DEX4, dexamethasone day 1 to 4.Time course of complete response (